Crosser Iq
Payments companies reported to CMS as associated with Crosser Iq. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Crosser Iq, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Crosser Iq
These are the largest totals companies reported as associated with Crosser Iq. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Timothy Manoni | Darien, CT | Vascular Surgery | $2,588.87 |
| Christopher Smolock | Astoria, NY | Vascular Surgery | $2,071.45 |
| Arthur Lee | Gainesville, FL | Interventional Cardiology | $1,657.21 |
| Massoud Arbabzadeh | Garden Grove, CA | Vascular & Interventional Radiology | $1,493.93 |
| Sandeep Banga | Carbondale, IL | Interventional Cardiology | $1,472.57 |
| Shailendra Singh | Allentown, PA | Interventional Cardiology | $1,407.25 |
| James Rothstein | Prestonsburg, KY | Vascular Surgery | $1,274.46 |
| Sidra Bhuller | Lansing, MI | Surgery | $1,254.78 |
| Fakhir Elmasri | Lakeland, FL | Vascular & Interventional Radiology | $1,065.65 |
| Anand Tarpara | Miami, FL | Vascular Surgery | $987.13 |
Prescribed Crosser Iq?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.